Subtitles section Play video Print subtitles leading by example, Indonesia's president received his country's first Kovar 19 vaccine on Wednesday following the launch of a mass immunization program. Officials hope to give more than 180 million people that job after authorities on Monday approved China's vaccine, made by sign of at Bard for emergency use. They've also ordered vaccine doses from AstraZeneca, Pfizer and biotech. Indonesia's president, who many called Jacoby was first up on received his at the presidential palace Cover 19. Vaccination is very important to break the chain of transmission, providing health protection and keeping us safe. It provides a peace of mind for the people of Indonesia and will help to accelerate economic recovery. Instead of vaccinating the elderly in front line workers first, like other countries are doing, Indonesia will start with younger, working people. This is partly because officials do not have enough data on older people from the Koran about clinical trials. Indonesia has said its trials showed China's vaccine had efficacy rate off 65% but Brazilian researchers said on Tuesday it was only 50% effective. The government is also keen to kick start the economy after it suffered its first recession in more than two decades due to the pandemic. But experts have warned not to see the vaccine is a silver bullet as more research needs to be done on whether vaccinated people can transmit the virus. Indonesia has one of the worst outbreaks in Asia, recording a daily record on more than 300 deaths on Tuesday on averaging around 9000 new infection today, there have been calls for the country to strengthen its test and praise regime alongside rolling out the vaccine.